{"nctId":"NCT00113087","briefTitle":"Trial of Angiotensin Converting Enzyme Inhibition in Infants With Single Ventricle--Pediatric Heart Network","startDateStruct":{"date":"2003-08"},"conditions":["Heart Defects, Congenital","Heart Failure, Congestive"],"count":230,"armGroups":[{"label":"Enalapril","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Enalapril"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo"]}],"interventions":[{"name":"Enalapril","otherNames":[]},{"name":"Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Less than or equal to 45 days of age\n* Age greater than 1 week if born at 35 weeks gestation\n* Single ventricle physiology\n* Stable systemic and pulmonary blood flow\n* Planned Glenn shunt surgery (or variant known as hemi-Fontan)\n\nExclusion Criteria:\n\n* Birth weight less than or equal to 2.5 kg if gestational age is greater than or equal to 38 weeks\n* Birth weight less than the 10th percentile for gestational age if gestational age is 35 to 37 weeks\n* Less than 35 weeks gestation\n* Anatomic diagnosis of pulmonary atresia with intact ventricular septum\n* Less than 3 days after palliative cardiac surgical procedure, if performed\n* Aortic oxygen saturation less than 65%\n* Current mechanical ventilatory support\n* Current intravenous inotropic support\n* Creatinine greater than 1.0 mg/dL\n* Absolute neutrophil count less than 1,000 cells/mL\n* Chromosomal or recognizable phenotypic syndrome of noncardiac congenital abnormalities associated with growth failure (e.g., Trisomy 21, Noonan's syndrome, Turner's syndrome)\n* Prior ACE inhibitor use for greater than 7 consecutive days","healthyVolunteers":false,"sex":"ALL","maximumAge":"45 Days","stdAges":["CHILD"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Weight-for-age Z-score at 14 Months of Age","description":"Weight-for-age z-score at 14 months of age. In primary analysis outcome is defined as predicted mean of weight z-score at age 14 months based on longitudinal modeling(and adjusted for baseline values)","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.62","spread":"0.13"},{"groupId":"OG001","value":"-0.42","spread":"0.13"}]}]}]},{"type":"SECONDARY","title":"Height-for-age Z-score","description":"Height-for-age z-score at 14 months of age. In primary analysis outcome is defined as predicted mean of height z-score at age 14 months based on longitudinal modeling (adjusted bor baseline value)","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.00","spread":"0.13"},{"groupId":"OG001","value":"-0.86","spread":"0.13"}]}]}]},{"type":"SECONDARY","title":"Head Circumference-for-age Z-score","description":"Head circumference-for-age z-score at 14 months of age.In primary analysis outcome is defined as predicted mean of Head circumference z-score at age 14 months based on longitudinal modeling(and adjusted for baseline values)","paramType":"LEAST_SQUARES_MEAN","dispersionType":"Standard Error","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.55","spread":"0.17"},{"groupId":"OG001","value":"0.09","spread":"0.17"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Ross Heart Failure Class I","description":"Class I is defined as having no limitations or symptoms of heart failure. Classes II to IV include increasing degrees of growth failure, prolonged feeding time, tachypnea, diaphoresis, and in older children, dyspnea on exercise.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"53","spread":null},{"groupId":"OG001","value":"56","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Ross Heart Failure Class I","description":"Class I is defined as having no limitations or symptoms of heart failure. Classes II to IV include increasing degrees of growth failure, prolonged feeding time, tachypnea, diaphoresis, and in older children, dyspnea on exercise.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"72","spread":null},{"groupId":"OG001","value":"77","spread":null}]}]}]},{"type":"SECONDARY","title":"B-Type Natriuretic Peptide","description":"B-Type Natriuretic Peptide (BNP) level.","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"79","spread":null},{"groupId":"OG001","value":"84","spread":null}]}]}]},{"type":"SECONDARY","title":"B-type Natriuretic Peptide Level","description":"B-type natriuretic peptide (BNP) level.","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"25","spread":null},{"groupId":"OG001","value":"39","spread":null}]}]}]},{"type":"SECONDARY","title":"Neurodevelopmental Status (PDI): the Bayley Scales of Infant Development,Psychomotor Development Index Z-score","description":"Neurodevelopmental status (PDI):\n\nthe Bayley Scales of Infant Development: Psychomotor Development index z-score .","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.29","spread":"1.19"},{"groupId":"OG001","value":"-1.32","spread":"1.22"}]}]}]},{"type":"SECONDARY","title":"Neurodevelopmental Status(MDI): Bayley Scales of Infant Development, Mental Developmental Index Z-score","description":"Neurodevelopmental status(MDI):Bayley Scales of infant development, Mental Developmental Index z-score .","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.26","spread":"0.91"},{"groupId":"OG001","value":"-0.33","spread":"1.02"}]}]}]},{"type":"SECONDARY","title":"Neurodevelopmental Status (FSII)","description":"Functional status II (Revised) Total Score. Scale ranges up to 100.00, the higher the better. The score presents an instrument for assessing health status for children surviving long term with chronic physcial disorders.","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"96.4","spread":null},{"groupId":"OG001","value":"96.4","spread":null}]}]}]},{"type":"SECONDARY","title":"MacArthur-Bates Inventory -Phrases Understood","description":"MacArthur-Bates Communicative Development inventory( Words and Gestures)-Phrases Understood z-score.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.48","spread":"1.11"},{"groupId":"OG001","value":"-0.92","spread":"1.17"}]}]}]},{"type":"SECONDARY","title":"MacArthur-Bates Inventory -Words Understood","description":"MacArthur-Bates Communicative Development inventory( Words and Gestures)-Words Understood z-score.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.46","spread":"0.91"},{"groupId":"OG001","value":"-0.82","spread":"0.83"}]}]}]},{"type":"SECONDARY","title":"MacArthur-Bates Inventory -Total Gestures","description":"MacArthur-Bates Communicative Development inventory( Words and Gestures)-Total Gestures z-score.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.86","spread":"1.07"},{"groupId":"OG001","value":"-1.31","spread":"0.97"}]}]}]},{"type":"SECONDARY","title":"MacArthur-Bates Inventory -Words Produced","description":"MacArthur-Bates Communicative Development inventory( Words and Gestures)-Words Produced z-score.","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.60","spread":null},{"groupId":"OG001","value":"-0.63","spread":null}]}]}]},{"type":"SECONDARY","title":"Ejection Fraction (%)","description":"Two-dimensional echocardiography endpoint -Total Ejection Fraction (%) per Core Laboratory assessment. Ejection Fraction % is defined as the percentage of the stroke volume (i.e. difference between end-diastolic and end-systolic volumes) in a ventricle relative to end-diastolic volume.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"57.9","spread":"9.8"},{"groupId":"OG001","value":"56.6","spread":"10.2"}]}]}]},{"type":"SECONDARY","title":"Ejection Fraction (%)","description":"Two-dimensional echocardiography endpoint -Total Ejection Fraction (%) per Core Laboratory assessment. Ejection Fraction (%) is defined as percentage of stroke volume of a ventricle (i.e. the difference between end diastolic and end systolic volumes)relative to end diastolic volume.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"59.3","spread":"9.6"},{"groupId":"OG001","value":"57.9","spread":"10.4"}]}]}]},{"type":"SECONDARY","title":"Ventricular Mass","description":"Two-dimensional echocardiography endpoint - Total Ventricular mass (g) per Core Laboratory assessment.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"25.5","spread":"9.2"},{"groupId":"OG001","value":"28.1","spread":"10.6"}]}]}]},{"type":"SECONDARY","title":"Ventricular Mass","description":"Two-Dimensional Echocardiography endpoint-Total Ventricular mass (g) per Core Laboratory assessment. Range from 15.60 to 70.40","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"31.4","spread":"10.3"},{"groupId":"OG001","value":"34.4","spread":"11.4"}]}]}]},{"type":"SECONDARY","title":"Ventricular Mass Z-score","description":"Two-dimensional echocardiography endpoint -Total Ventricular mass z-score per Core Laboratory assessment.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4.0","spread":"2.9"},{"groupId":"OG001","value":"4.9","spread":"3.3"}]}]}]},{"type":"SECONDARY","title":"Ventricular Mass Z-score","description":"Two-dimensional echocardiography endpoint -Total Ventricular mass z-score per Core Laboratory assessment.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.5","spread":"2.3"},{"groupId":"OG001","value":"3.1","spread":"2.5"}]}]}]},{"type":"SECONDARY","title":"End-diastolic Volume","description":"Two-Dimensional Echocardiography endpoint - Total End-diastolic volume (ml) per Core Laboratory assessment.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"24.1","spread":"10.1"},{"groupId":"OG001","value":"23.2","spread":"9.0"}]}]}]},{"type":"SECONDARY","title":"End-diastolic Volume","description":"Two-Dimensional Echocardiography endpoint - Total End-diastolic volume (ml) per Core Laboratory assessment.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"29.2","spread":"10.0"},{"groupId":"OG001","value":"30.7","spread":"11.3"}]}]}]},{"type":"SECONDARY","title":"End Diastolic Volume Z-score","description":"Two-dimensional echocardiography endpoint -total End diastolic volume z-score per Core Laboratory assessment.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.3","spread":"2.5"},{"groupId":"OG001","value":"2.1","spread":"2.5"}]}]}]},{"type":"SECONDARY","title":"End-diastolic Volume Z-score","description":"Two-dimensional echocardiography endpoint -total end-diastolic volume z-score per Core Laboratory assessment.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.1","spread":"2.1"},{"groupId":"OG001","value":"1.3","spread":"2.4"}]}]}]},{"type":"SECONDARY","title":"Ventricular Mass to Volume Ratio","description":"Two-Dimensional Echocardiography endpoint -Ventricular Mass to Volume ratio per Core Laboratory assessment.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.15","spread":"0.43"},{"groupId":"OG001","value":"1.31","spread":"0.50"}]}]}]},{"type":"SECONDARY","title":"Ventricular Mass to Volume Ratio","description":"Two-Dimensional Echocardiography endpoint -Ventricular Mass to Volume ratio per Core Laboratory assessment.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.14","spread":"0.38"},{"groupId":"OG001","value":"1.20","spread":"0.44"}]}]}]},{"type":"SECONDARY","title":"Ventricular Filling Pressure","description":"Ventricular filling pressure measured by catherization","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"10.9","spread":"3.6"},{"groupId":"OG001","value":"11.1","spread":"4.0"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Moderate to Severe AV Valve Regurgitation","description":"Number of participants with Moderate to severe AV valve regurgitation.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"20","spread":null},{"groupId":"OG001","value":"32","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Moderate to Severe AV Valve Regurgitation","description":"Number of participants with moderate to severe AV valve regurgitation.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"11","spread":null},{"groupId":"OG001","value":"22","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":88,"n":115},"commonTop":["infection","Pulmonary/upper respiratory","gastrointestinal","Cardiac General","metabolic/laboratory"]}}}